2010 Annual Meeting
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111
December 10, 2010
Cancer Pharmacogenomics: From
Bench to Bedside
Program Host: Margie L. Clapper, PhD
Fox Chase Cancer Center
The goal of pharmacogenomics is to optimize the drug therapy and dosage for each patient based on known inherited differences in drug disposition and effect. Pharmacogenomics becomes particularly important in oncology where most drugs have a very narrow therapeutic index and toxicities can be life threatening. By understanding the genetic variation that contributes to both chemotherapeutic response and adverse events, oncologists will be able to tailor therapies to match the genetic profile of each individual. This conference will focus on recent advances in the field of cancer pharmacogenomic research and the plans to implement these disocveries into clincial practice.
Keynote Speaker: Dr. David Flockhart
Dr. David Flockhart is Chief of the Division of Clinical Pharmacology at Indiana University School of Medicine in Indianapolis and founder/leader of the Consortium on Breast Cancer Genomics. His research focuses on drug interactions and the contribution of genetics to inter-individual variability in drug response. His accomplishments include the development of a web-based tool to improve the rational prescribing of drugs, a site that is visited more than 20,000 times per month by physicians and scientists around the world.
Program
Morning Session
7:45-8:30
|
|
Registration & Continental Breakfast (Center Building)
Poster Setup (Robert C. Young Pavilion Atrium)
|
| 8:30 - 8:40 |
|
Fox
Chase Cancer Center Welcome: J. Robert Beck., MD, Senior Vice President
and Chief Academic Officer, Fox Chase Cancer Center
|
| 8:40-8:50 |
|
MAPS Welcome:
Vincent J. Aloyo, PhD; President, MAPS
|
| 8:50-9:00 |
|
Introduction
to Program, Margie L. Clapper, PhD, Professor, Co-Leader, Cancer Prevention and
Control Program and Keystone Program in Personalized Risk and Prevention, Fox
Chase Cancer Center
|
| 9:00-10:10 |
|
Keynote Speaker: David Flockhart, MD, PhD, Chief, Division of Clinical Pharmacology, Indiana
University School of Medicine, Indianapolis,
IN
“Pharmacogenetic Approaches to the Treatment of Breast Cancer"
|
| |
|
|
| 10:10-11:00 |
|
Rebecca Suk Heist, PhD, Massachusetts
General Hospital, Assistant Professor of Medicine, Harvard Medical School, Boston, MA
"Targeting Somatic Mutations in Lung Cancer: EGFR and ALK"
|
| |
|
|
| 11:00-11:30 |
|
Refreshment Break
|
| 11:30-12:20 |
|
Evgeny Krynetskiy, PhD,
DSc, Associate Professor, Pharmaceutical Sciences, Temple University School
of Pharmacy, Philadelphia, PA
“Beyond Thiopurine S-methyltransferase (TPMT): A View from the Bench"
|
| |
|
|
| 12:20-12:30 |
|
Koelle Award Presentation
|
| 12:35-2:30 |
|
Lunch
& Poster Viewing and Judging (Robert C. Young Pavilion Atrium)
|
Afternoon
Session
2:30 -3:20
|
|
Paul
Billings, MD, PhD, Chief Medical
Officer, Life Technologies, Inc., Carlsbad, CA
"Genomic
Medicine: the New Oncology Subspecialty?"
|
3:20-4:10
|
|
Howard McLeod, PharmD, Fred Eshelman
Distinguished Professor, Director, Institute of Pharmacogenomics and Individualized
Therapy, University
of North Carolina, Chapel Hill, NC
“Using the Genome to Guide Cancer Therapy"
|
4:10-4:30
|
|
Poster
Awards Presentations…Presented by Sri Ghatta, MAPS
Councilor
|
4:30-4:40
|
|
Concluding
Remarks - Margie L. Clapper, PhD
|
| 4:40-4:50 |
|
Induction of
new MAPS officers
|
5:00-5:45
|
|
Post meeting
reception- Robert C. Young Pavilion Atrium |
Note :
All speaker times include presentation and discussion
Pre-registration Fees:
- Undergraduate students and their mentors: no charge
- Graduate students: $25
- Postdoctoral fellows: $35
- All others: $130
Credit Cards will be accepted only for pre-registration.
Pre-registration deadline: November 30, 2010
On-site registration will be an additional $10. No credit cards will be accepted for on-site registration. On-site fees must be paid in cash or by check.
Download a PDF of the Program.
For meeting brochure and details, please contact
Jeanne E. Coughlin at 215-641-9569
For further information or questions about the meeting, please contact
Jan M. Kitzen, Executive Secretary, MAPS at:
email: jkitzen@verizon.net
phone: 610-489-4965
Reports from Previous Meetings
2009 Annual Scientific Meeting - November 2, 2009
Temple University Health Sciences Center College of Medicine, Philadelphia, PA
2008 Annual Scientific Meeting ( Abstracts and Program ) - November 11, 2008
GlaxoSmithKline, King of Prussia, PA
2007 Annual Scientific Meeting - October 8, 2007
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia
2006 Annual Scientific Meeting - October 27, 2006
Cephalon Pharmaceuticals and Adolor Pharmaceuticals, King of Prussia, PA
2004 Annual Scientific Meeting - October 15, 2004
Wyeth Pharmceuticals, Collegeville, PA
2003 Annual Scientific Meeting - October 10, 2003
University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, Stratford, NJ